Prognostic implication of microvascular invasion in biochemical failure in patients treated with radical prostatectomy

Urologia Internationalis

Volumn 70, Issue 4, 2003, Pages 297-302

  Ito, Keiichi ^a,b   Nakashima, Jun ^a   Mukai, Makio ^a   Asakura, Hirotaka ^a   Ohigashi, Takashi ^a   Saito, Shiro ^a   Tachibana, Masaaki ^a   Hata, Jun ichi ^a   Murai, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Biochemical failure; Microvascular invasion; Prostate cancer; Radical prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INFILTRATION; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MULTIVARIATE ANALYSIS; PATHOLOGY; PERINEUM; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SURVIVAL RATE; TREATMENT FAILURE;

AGED; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PELVIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0038300161     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070139     Document Type: Article

References (22)

1. Lerner SE, Blute ML, Zincke H: Risk factors for progression in patients with prostate cancer treated with radical prostatectomy. Semin Urol Oncol 1996;14(suppl 2):12-20.
2. Murphy GP, Mettlin C, Menck H, Winchester DP, Davidson AM: National patterns of prostate cancer treatment by radical prostatectomy: Results of a survey by the American College of Surgeons Commission on Cancer. J Urol 1994;152:1817-1819.
3. Trapasso JG, deKernion JB, Smith RB, Dorey F: The incidence and significance of detectable levels of serum prostate-specific antigen after radical prostatectomy. J Urol 1994;152:1821-1825.
4. Oesterling JE: Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-923.
5. Bahnson RR, Dresner SM, Gooding W, Becich MJ: Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens. Prostate 1989;15/2:149-155.
6. McNeal JE, Yemoto CE: Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma. Am J Surg Pathol 1996;20:1351-1360.
7. Salomao DR, Graham SD, Bostwick DG: Microvascular invasion in prostate cancer correlates with pathologic stage. Arch Pathol Lab Med 1995;119:1050-1054.
8. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM: Biological determinants of cancer progression in men with prostate cancer. JAMA 1999;281:1395-1400.
9. van den Ouden D, Kranse R, Hop WC, van der Kwast TH, Schroder FH: Microvascular invasion in prostate cancer: Prognostic significance in patients treated by radical prostatectomy for clinically localized carcinoma. Urol Int 1998;60/1:17-24.
10. Partin AW, Borland RN, Epstein JI, Brendler CB: Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. J Urol 1993;150/1:142-146.
11. Catalona WJ, Smith DS: 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994;152:1837-1842.
12. Slawin KM, Ohori M, Dillioglugil O, Scardino PT: Screening for prostate cancer: An analysis of the early experience. CA Cancer J Clin 1995;45/3:134-147.
13. Lerner SE, Blute ML, Bergstralh EJ, Bostwick DG, Eickholt JT, Zincke H: Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol 1996;156/1:137-143.
14. Epstein JI, Carmichael M, Partin AW, Walsh PC: Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow-up. J Urol 1993;149:1478-1481.
15. Epstein JI, Carmichael MJ, Pizov G, Walsh PC: Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long-term follow-up. J Urol 1993;150/1:135-141.
16. Epstein JI, Carmichael M, Walsh PC: Adenocarcinoma of the prostate invading the seminal vesicle: Definition and relation of tumor volume, grade and margins of resection to prognosis. J Urol 1993;149:1040-1045.
17. Lopez JI, Angulo JC: The prognostic significance of vascular invasion in stage T1 bladder cancer. Histopathology 1995;27/1:27-33.
18. Lee AK, DeLellis RA, Silverman ML, Wolfe HJ: Lymphatic and blood vessel invasion in breast carcinoma: A useful prognostic indicator? Hum Pathol 1986;17:984-987.
19. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE, Scardino PT: Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989;142:332-336.
20. Endrizzi J, Seay T: The relationship between early biochemical failure and perineural invasion in pathological T2 prostate cancer. BJU Int 2000;85:696-698.
21. Villers A, McNeal JE, Redwine EA, Freiha FS, Stamey TA: The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 1989;142:763-768.
22. Stone NN, Stock RG, Parikh D, Yeghiayan P, Unger P: Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate. J Urol 1998;160:1722-1726.